Literature DB >> 29651674

Intestinal Microbiota and Kidney Diseases.

Ao Xie1, Jie Sheng1, Feng Zheng2.   

Abstract

Kidney diseases are common and the incidence rate is increasing. Gut microbiota is involved in metabolic and immune regulation of the host. Genetic, alimentary and environmental disease factors may change gut flora and increase opportunistic and pathogenic bacteria, contributing to immune or non-immune mediated kidney diseases including IgA nephropathy and diabetic nephropathy. Additionally, bacterial metabolites may be a source of uremic toxins. Thus, identification of diversity, composition, and metabolic and immunologic features of gut bacteria in chronic kidney diseases may help understand pathogenetic mechanism and develop therapy for diseases.

Entities:  

Keywords:  IgA nephropathy; chronic kidney disease; microbiota; uremia

Mesh：

Year:  2018        PMID： 29651674     DOI： 10.1007/s11655-017-2927-5

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


  14 in total

1.  High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease.

Authors:  Vidya M Raj Krishnamurthy; Guo Wei; Bradley C Baird; Maureen Murtaugh; Michel B Chonchol; Kalani L Raphael; Tom Greene; Srinivasan Beddhu
Journal:  Kidney Int       Date:  2011-10-19       Impact factor: 10.612

2.  A human gut microbial gene catalogue established by metagenomic sequencing.

Authors:  Junjie Qin; Ruiqiang Li; Jeroen Raes; Manimozhiyan Arumugam; Kristoffer Solvsten Burgdorf; Chaysavanh Manichanh; Trine Nielsen; Nicolas Pons; Florence Levenez; Takuji Yamada; Daniel R Mende; Junhua Li; Junming Xu; Shaochuan Li; Dongfang Li; Jianjun Cao; Bo Wang; Huiqing Liang; Huisong Zheng; Yinlong Xie; Julien Tap; Patricia Lepage; Marcelo Bertalan; Jean-Michel Batto; Torben Hansen; Denis Le Paslier; Allan Linneberg; H Bjørn Nielsen; Eric Pelletier; Pierre Renault; Thomas Sicheritz-Ponten; Keith Turner; Hongmei Zhu; Chang Yu; Shengting Li; Min Jian; Yan Zhou; Yingrui Li; Xiuqing Zhang; Songgang Li; Nan Qin; Huanming Yang; Jian Wang; Søren Brunak; Joel Doré; Francisco Guarner; Karsten Kristiansen; Oluf Pedersen; Julian Parkhill; Jean Weissenbach; Peer Bork; S Dusko Ehrlich; Jun Wang
Journal:  Nature       Date:  2010-03-04       Impact factor: 49.962

3.  Colonic contribution to uremic solutes.

Authors:  Pavel A Aronov; Frank J-G Luo; Natalie S Plummer; Zhe Quan; Susan Holmes; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

4.  p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease.

Authors:  Cheng-Jui Lin; Han-Hsiang Chen; Chi-Feng Pan; Chih-Kuang Chuang; Tuen-Jen Wang; Fang-Ju Sun; Chih-Jen Wu
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

5.  Chronic kidney disease alters intestinal microbial flora.

Authors:  Nosratola D Vaziri; Jakk Wong; Madeleine Pahl; Yvette M Piceno; Jun Yuan; Todd Z DeSantis; Zhenmin Ni; Tien-Hung Nguyen; Gary L Andersen
Journal:  Kidney Int       Date:  2012-09-19       Impact factor: 10.612

Review 6.  The intestine-renal connection in IgA nephropathy.

Authors:  Rosanna Coppo
Journal:  Nephrol Dial Transplant       Date:  2014-11-11       Impact factor: 5.992

7.  Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis.

Authors:  Krzysztof Kiryluk; Zina Moldoveanu; John T Sanders; T Matthew Eison; Hitoshi Suzuki; Bruce A Julian; Jan Novak; Ali G Gharavi; Robert J Wyatt
Journal:  Kidney Int       Date:  2011-02-16       Impact factor: 10.612

Review 8.  The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease.

Authors:  Hans-Joachim Anders; Kirstin Andersen; Bärbel Stecher
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

9.  The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease.

Authors:  Josephine M Ambruzs; Patrick D Walker; Christopher P Larsen
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 8.237

10.  Discovery and validation of a new class of small molecule Toll-like receptor 4 (TLR4) inhibitors.

Authors:  Matthew D Neal; Hongpeng Jia; Benjamin Eyer; Misty Good; Christopher J Guerriero; Chhinder P Sodhi; Amin Afrazi; Thomas Prindle; Congrong Ma; Maria Branca; John Ozolek; Jeffrey L Brodsky; Peter Wipf; David J Hackam
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240
View more
  1 in total

1.  Contribution of 'clinically negligible' residual kidney function to clearance of uremic solutes.

Authors:  Stephanie M Toth-Manikowski; Tammy L Sirich; Timothy W Meyer; Thomas H Hostetter; Seungyoung Hwang; Natalie S Plummer; Xin Hai; Josef Coresh; Neil R Powe; Tariq Shafi
Journal:  Nephrol Dial Transplant       Date:  2020-05-01       Impact factor: 5.992
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.